Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Advanced Medicine

Business & Regulation Standards & Regulation

Unproven Stem Cell Ruling Creates Uncertainty

| Stephanie Sutton | 2 min read

ISCT speaks out after US court rules that stem cell therapy does not fall under FDA jurisdiction.

Business & Regulation Profession

Change Is the Only Constant

| Angus Stewart | 9 min read

Diversity, support networks, and unexpected journeys: what nine years of C&G biz wisdom can teach us

Manufacture Advanced Medicine

The Patient Experience Trumps All

| Cedric Picaud | 3 min read

How can companies realistically incorporate patient-centric practices into cell and gene product development?

Business & Regulation Trends & Forecasts

An Eye on the Higher Branches

| Angus Stewart | 4 min read

Can cell and gene therapy help bring an end to rare eye diseases?

Business & Regulation Profession

Dreams, Chimps, and Chocolate Cakes

| Angus Stewart | 9 min read

ISCT’s new president talks platforms, regulation, and knowledge-transfer for the next generation

Business & Regulation Profession

CGT 2022: What’s Next?

| Angus Stewart | 9 min read

What happened at ISCT 2022’s return to in-person conferencing – and what can a new film release do for advanced therapy?

Business & Regulation Trends & Forecasts

Post-Conference Reflections

| Angus Stewart | 9 min read

The International Society for Cell & Gene Therapy convened in person for the first time in two years. We spoke to an attendee for an insight

Business & Regulation Business Practice

Champions of Cell and Gene Therapy

| Angus Stewart | 7 min read

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many

Manufacture Bioprocessing - Upstream & Downstream

Delving into the Trends of the Biopharma Industry

| Stephanie Sutton

The Medicine Maker and NIBRT present the Biopharma Trends Leaders’ Report 2022.

Manufacture Advanced Medicine

The Cell and Gene Endgame

| Sponsored by Charles River | 3 min read

Cell and gene therapy manufacturers need to make better plasmid design decisions with commercialization in mind.


Latest White Papers

How to Improve the Capturing of Antibody Fragments

| Contributed by Tosoh

Accelerate innovation and manufacturing to better serve patients

| Contributed by GenScript Probio

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register